Microfluidics Market will register a CAGR of 14.4% through 2026

1
Cytomegalovirus Treatment Market to be valued at
US 145.5 Mn by 2028

• Healthcare, Pharmaceuticals Medical Devices
• January 2019

Report Id REP-GB-8665 Status Publish Category
Healthcare, Pharmaceuticals Medical Devices
2
AboutFuture Market Insights
Future Market Insights (FMI) is a premier
provider of syndicated research reports, custom
research reports, and consulting services. We
deliver a complete packaged solution, which
combines current market intelligence, statistical
anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive
framework, and future market trends. We provide
research services at a global as well as regional
level key regions include GCC, ASEAN,
and BRIC. Our offerings cover a broad spectrum of
industries including Chemicals, Materials,
Energy, Technology, Healthcare, and Retail. We
have a global presence with delivery centers
across India specializing in providing global
research reports and country research reports.
FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Research Capabilities
Sector Coverage

• Customized Research
• Syndicated Research
• Investment Research
• Social Media Research

• Automotive and Transportation
• Electronics, Semiconductor, and ICT
• Retail and Consumer Products
• Industrial Automation and Equipment

• Chemicals Materials
• Food and Beverages
• Services and Utilities
• Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please
contact Hari. T (Sr. Manager - Global Business
Development) T 44 (0) 20 7692 8790 D 44
20 3287 4268 Email hari.t_at_futuremarketinsights.co
m
3
Research Methodology (1/2)

• Systematic Research Approach

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc.
PMR formulates a detailed discussion guide to conduct expert and industry interviews
PMR develops a list of industry players (manufacturers), distributors, retailers and industry experts
PMR conducts interviews with industry experts, industry players, distributors and retailers
Data is validated by triangulation method, wherein secondary, primary and PMR analysis contribute to the final data
Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry
PMR delivers industry insights and information in the required format (PDF)

• Identifying key opinion leaders
• Questionnaire design
• In-depth interviews
• Coverage across value chain

• Key industry experts
• Channel study
• Developments
• Market dynamics
• Products
• Conclusions

SOLUTION

• Market participants
• Key strengths
• Product portfolio
• Mapping as per value chain
• Key focus segments

Primary Research
Secondary Research
Paid Publications

• Linkedin
• Zoominfo
• Salesforce
• Avention

• Factiva
• GBI
• Genios
• Meltwater

• Company websites
• Company annual reports
• White papers
• Financial reports

includes sources of databases
4
Cytomegalovirus Treatment Market Analysis

• A new study by the company, titled '
  Cytomegalovirus Treatment Market Global Industry
  Analysis 2013-2017 and Opportunity Assessment
  2018-2028,' points out the key structural outlook
  for the cytomegalovirus treatment market. A large
  number of people are infected by Cytomegalovirus
  (CMV) virus during their life course, mostly in
  indications that are invasively treated like
  organ transplantation and stem cell
  transplantation. The virus is found active post
  treatment or later stages of any other treatment
  like mentioned before. Cytomegaloviruses are
  among the most prevalent viral infections present
  on a global level. Transmission of such
  cytomegalovirus occurs via direct contact with
  the infected person or infected secretions.
  Cytomegalovirus treatment requires drug in
  correct stage of activation of the virus. The
  presence of this virus is very common, but the
  activation requires different mediums and time of
  breeding. There are many indications related to
  cytomegalovirus conditions like organ
  transplantation, AIDS, congenital CMV and most
  recent stem cell transplantations
• Infants can get infected by this cytomegalovirus
  in utero. A major portion of prevalent population
  comes out to be infants, congenital
  cytomegalovirus estimates to account for a great
  number of cases which is mostly observed in
  developed countries like the U.S. Being
  asymptomatic at birth it is likely ignored for
  having a cytomegalovirus treatment and cause some
  serious health issues. Cytomegalovirus is
  responsible for a number health disorders in
  infants like hearing disorders, seizures, rashes
  and SNHL
• Request Sample Report_at_ https//www.futuremarketins
  ights.com/reports/sample/rep-gb-8665

5
Cytomegalovirus Treatment Market Analysis

• The market for cytomegalovirus treatment is
  primarily based on off-label drugs prescription.
  As the condition is either treated by some
  therapeutic relief or preventive measures before
  its activation in blood cells. There are some
  major drug types that are being used for
  cytomegalovirus treatment, though primarily
  antiviral drug class is used for such condition.
  Valcyte (Valganciclovir hydrochloride)
  manufactured by Roche is one of the rare branded
  drugs available for cytomegalovirus treatment.
  Aside from such medications most of the
  cytomegalovirus treatment market is driven by
  generic drugs such as foscarnet and ganciclovir.
  CMV-IG, is a biologic which is available in the
  US market since 1992. And most of the drug
  including valacyclovir and acyclovir are used
  off-label for cytomegalovirus treatment. A
  dynamic nature of drug approval process can also
  limit some drugs which are expected to provide
  good revenue share to the cytomegalovirus
  treatment market.
• The market for cytomegalovirus treatment hence
  leaves a greater untapped opportunities for
  manufacturers to a come with a technology solely
  for cytomegalovirus condition. It would not only
  assure a good fortune turn for the company but
  would also drastically effect the cytomegalovirus
  treatment market.
• The development present for cytomegalovirus
  treatment is progressive, with many molecules in
  various stages of clinical development. There are
  more than 350 clinical trials being performed for
  cytomegalovirus treatment all around the globe.
  Europe and North America accounts for the highest
  number of registered clinical trials for
  cytomegalovirus treatment. Late-stage pipeline
  consists of exceptional drugs which are expected
  to enter the market within the forecast period
  and is presumed to have a positive outlook in the
  global cytomegalovirus treatment market.

6
Cytomegalovirus Treatment Market Analysis

• The global cytomegalovirus treatment market
  revenue is inclined towards the developed regions
  of North America and parts of Latin America. With
  rise in awareness for cytomegalovirus treatment,
  and increase in number of parallel combinations,
  the cytomegalovirus treatment market is estimated
  to rise with a positive CAGR over the period of
  forecast. Greater number of drugs for
  cytomegalovirus treatment are in pipeline phase.
  And in coming few years the number of sole drugs
  for cytomegalovirus treatment is going to rise,
  presently the trend is towards adopting off-label
  drugs. Key companies analyzed for cytomegalovirus
  treatment market which provides a selection of
  drugs include Merck Co. Inc., Mylan N.V.,
  Chimerix, Inc., Thermo Fisher Scientific, Abbott,
  Becton, Dickinson and Company, Johnson Johnson,
  Bio-Rad Laboratories Inc., F. Hoffmann-La Roche
  Ltd and Pfizer.
• Request to View Methodology _at_ https//www.futurema
  rketinsights.com/askus/rep-gb-8665

7
To know more about us, please visit our website
www.futuremarketinsights.com For sales queries
or new topics email us on sales_at_futuremarketinsi
ghts.com For media queries, contact the press
office at press_at_futuremarketinsights.com For
other queries contactHari. T (Sr. Manager -
Global Business Development) Future Market
Insights 3rd Floor,207 Regent Street, London
W1B 3HH T 44 20 7692 8790 D 44 20 3287
4268 Email hari.t_at_futuremarketinsights.com
Thank You
Future Market Insights Global Consulting
Private Limited (FMI)